Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Mathematical Biology|February 16, 2008
Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivityFrédéric Frank WellerJournal of Mathematical Biology|January 8, 2010
A free boundary problem modeling thrombus growth: model development and numerical simulation using the level set methodFrédéric Frank WellerActa Crystallographica. Section C, Structural Chemistry|May 5, 2018
Between MOFs and molecules: organolead(IV) compounds with chain structuresAbdel Fattah Shihada, Frank Weller, Werner MassaPediatric Rheumatology Online Journal|November 9, 2017
Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritisGerd Horneff, Ariane Klein, Gerd Ganser, et al.Rheumatology International|February 16, 2021
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registryFranz Thiele, Ariane Klein, Daniel Windschall, et al.Annals of the Rheumatic Diseases|April 18, 2020
Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritisAriane Klein, Kirsten Minden, Anton Hospach, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritisStephanie Glaesener, Tâm D Quách, Nils Onken, et al.ACR Open Rheumatology|April 4, 2026
Effectiveness of Canakinumab for First-Line Steroid-Free Treatment in Systemic-Onset Juvenile Idiopathic Arthritis and Juvenile Still DiseaseGerd Horneff, Tilman Kallinich, Markus Hufnagel, et al.Arthritis Research & Therapy|November 25, 2016
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumabGerd Horneff, Ariane Klein, Jens Klotsche, et al.Rheumatology (Oxford, England)|June 2, 2009
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritisGerd Horneff, Annette Ebert, Sigrid Fitter, et al.Pageof 4